Unique Imaging Findings of Neurologic Phantosmia Following Pfizer-BioNtech COVID-19 Vaccination: A Case Report. Issue 3 (June 2021)

• Record Type: Journal Article
• Authors: Keir, Graham; Maria, Naomi I.; Kirsch, Claudia F.E.
• Is Part Of: Topics in magnetic resonance imaging. Volume 30:Issue 3(2021)
• Publication Date: 2021-06
• Subjects: COVID-19 vaccine -- magnetic resonance imaging -- olfactory dysfunction -- phantosmia; Magnetic resonance imaging -- Periodicals; 616.07548
• DOI: 10.1097/RMR.0000000000000287
• Languages: English
• ISSNs: 0899-3459

Abstract

Abstract : Abstract: Olfactory dysfunction related to SARS-CoV-2 infection and COVID-19 disease is now well established in the literature. In December 2020, the FDA approved the Pfizer-BioNTech and Moderna vaccines for use in preventing COVID-19 in the United States. To the best of our knowledge, this is the first report of a phantosmia post-Pfizer COVID-19 vaccination, with positive magnetic resonance imaging radiographic findings in a patient with documented absence of infection by SARS-CoV-2 virus or concomitant sinonasal disease.